Navigation Links
Stryker Announces Exclusive Collaboration With RegenLab
Date:7/8/2011

SAN DIEGO, July 8, 2011 /PRNewswire/ -- Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine meeting that it has entered into an exclusive collaboration with RegenLab SA to distribute Stryker's RegenKit-THT, a one-step system designed for the safe and rapid preparation of autologous platelet-rich plasma (A-PRP) from a small sample of blood at the patient's point of care.

A-PRP contains an increased concentration of platelets, while maintaining physiological levels of leukocytes (white blood cells).  When activated, platelets have been found to release growth factors which may participate in the healing process, and a multitude of proteins and bioactive factors critical to the healing process and the recruitment of cells.  Leukocytes are responsible primarily for defending the body against infection, but are also key players during the initial inflammation phase of tissue healing.

In comparison to competitive offerings, the A-PRP prepared using Stryker's RegenKit-THT provides the highest platelet recovery and viability(1), while its simplified single tube preparation, with a minimal eight minute centrifuge spin time and reduced number of steps, helps maximize efficiency in the office and O.R.

"The RegenKit-THT system is the result of 10 years of scientific research in tissue regeneration and is designed to provide an autologous and physiological solution to promote a biological environment for regenerative cells enrichment.  RegenLab is pleased to collaborate with Stryker, a leader in medical technologies and innovation, which will allow for the widespread distribution of our A-PRP technology," said Antoine Turzi, Founder and CEO of RegenLab SA.

"The addition of the RegenKit for PRP therapy to Stryker's Joint Preservation Biologics portfolio allows us to provide surgeons with this emerging therapy for orthopaedic applications.  We're pleased to collaborate with RegenLab on the distribution of this system," said Matt Moreau, Vice President & General Manager, Stryker Joint Preservation.

To see a demonstration of this product, please visit Stryker at booth #503 at AOSSM.

About Stryker OrthopaedicsStryker Orthopaedics is a division of the Stryker Corporation, one of the world's leading medical technology companies. Stryker Orthopaedics offers an extensive orthopaedic product portfolio including hip, knee and upper extremity reconstructive devices, bone cement, trauma implants, bone substitutes, joint preservation products and spine systems. For more information about Stryker Orthopaedics, visit: http://www.stryker.com/en-us/products/Orthopaedics/index.htm

About StrykerStryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

(1) Study Report – Regen™ THT Tube Performance Testing, USFDA 510(k) BK090048, May 2010, Data on file at RegenLab, Switzerland.

NL11-FB-CO-1532Contact:Jeanine GuilfoyleStryker Orthopaedics201-831-6277jeanine.guilfoyle@stryker.com
'/>"/>

SOURCE Stryker Orthopaedics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Launches VersiTomic G-Lok™
2. Stryker Orthopaedics Launches Its First iPad™ Apps for Surgeons, Available Through Apples App Store(SM)
3. Stryker Features Tissue-Preservation Hip Arthroscopy Platform, Sponsors Surgeon Education Events at the AAOS Annual Meeting
4. Fred Funk Becomes Spokesperson for Stryker Orthopaedics
5. Stryker Receives FDA 510(k) Clearance to Market Modular Dual Mobility Acetabular (Hip) System
6. Stryker Declares a $0.18 Per Share Quarterly Dividend
7. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
8. Stryker Reports 9% Sales Growth, 13% Adjusted Net Earnings Growth for Quarter Ended December 31, 2010
9. Stryker Corporation Named One of FORTUNE Magazines 100 Best Companies to Work For
10. TriMed, Inc. Announces Licensing Agreement with Stryker
11. Stryker Increases Expected 2010 Results and Provides 2011 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... FRANCISCO , Sept. 12, 2017  ValGenesis ... Management Solutions (VLMS), is pleased to announce the ... a member of its Board of Directors and ... ValGenesis VLMS enables life science companies to manage ... the use of paper in this process. Furthermore, ...
(Date:9/9/2017)... , Sept. 9, 2017  Eli Lilly and Company ... and secondary endpoint data for lasmiditan, an investigational, oral, ... demonstrated statistically significant improvements compared to placebo in the ... today at the 18th Congress of the International Headache ... "The data presented today demonstrate lasmiditan,s potential to ...
(Date:9/7/2017)... , Sept. 7, 2017 Caris Life ... on fulfilling the promise of precision medicine, today ... the benefits of its molecular profiling approach in ... comprehensive genomic profiling plus (CGP+) with Caris Molecular ... tumor on a molecular level, leading to more ...
Breaking Medicine Technology:
(Date:9/22/2017)... Greenwich, Connecticut (PRWEB) , ... September 22, 2017 ... ... to conquering Lyme and other tick-borne diseases through research, education and awareness, today ... , A noted immunologist and microbiologist, Dr. Sellati has more than 20 ...
(Date:9/21/2017)... Angeles, CA (PRWEB) , ... September 21, 2017 ... ... a lunch and learn with Infinity Behavioral Health Services for professionals in the ... in a Commercial Payer Audit . , Insurance companies and state and ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... or exercise more try taking a more holistic approach and use natural alternatives ... Amazon essential oil collection is certified USDA guaranteeing that, the new line of ...
(Date:9/21/2017)... ... September 21, 2017 , ... A new addiction treatment ... a time when Virginia faces an opioid epidemic. , Last year, ... of 38 percent from 2015, underscoring the need for additional addiction treatment options. ...
(Date:9/20/2017)... ... September 20, 2017 , ... Reflections Recovery Center, a men-only ... The Joint Commission for chemical dependency and behavioral health services. , The Joint ... organizations that meet the commission’s rigorous standards. Accreditation by The Joint Commission is ...
Breaking Medicine News(10 mins):